Lincoln National (LNC) Set to Announce Quarterly Earnings on Thursday

Lincoln National (NYSE:LNC) is scheduled to be announcing its earnings results before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of $1.25 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

Lincoln National (NYSE:LNC) last released its quarterly earnings results on Thursday, February 8th. The financial services provider reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.32 by $0.13. The business had revenue of $1.97 billion during the quarter, compared to analyst estimates of $4.44 billion. Lincoln National had a negative net margin of 6.46% and a positive return on equity of 20.81%. On average, analysts expect Lincoln National to post $6 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Lincoln National Price Performance

LNC opened at $28.64 on Thursday. The company has a fifty day simple moving average of $28.41 and a 200 day simple moving average of $26.38. The firm has a market cap of $4.87 billion, a price-to-earnings ratio of -5.74, a PEG ratio of 0.18 and a beta of 1.81. Lincoln National has a twelve month low of $18.50 and a twelve month high of $32.43. The company has a current ratio of 0.26, a quick ratio of 0.26 and a debt-to-equity ratio of 0.96.

Lincoln National Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Wednesday, April 10th will be paid a dividend of $0.45 per share. The ex-dividend date of this dividend is Tuesday, April 9th. This represents a $1.80 dividend on an annualized basis and a yield of 6.29%. Lincoln National’s dividend payout ratio (DPR) is -36.07%.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Keefe, Bruyette & Woods increased their price objective on shares of Lincoln National from $30.00 to $32.00 and gave the company a “market perform” rating in a research note on Wednesday, April 10th. StockNews.com upgraded shares of Lincoln National from a “sell” rating to a “hold” rating in a research note on Monday, April 15th. The Goldman Sachs Group increased their price objective on shares of Lincoln National from $29.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, January 9th. Jefferies Financial Group upgraded shares of Lincoln National from an “underperform” rating to a “hold” rating in a research note on Monday, February 12th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Lincoln National from $26.00 to $29.00 and gave the company an “underweight” rating in a research note on Tuesday, April 2nd. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $28.45.

Insider Activity at Lincoln National

In other news, Director Owen Ryan acquired 10,000 shares of the business’s stock in a transaction that occurred on Friday, February 9th. The shares were purchased at an average cost of $25.90 per share, for a total transaction of $259,000.00. Following the transaction, the director now directly owns 10,000 shares in the company, valued at approximately $259,000. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.54% of the stock is currently owned by insiders.

Lincoln National Company Profile

Lincoln National Corporation, through its subsidiaries, operates multiple insurance and retirement businesses in the United States. It operates in four segments: Life Insurance, Annuities, Group Protection, and Retirement Plan Services. The Life Insurance segment provides life insurance products, including term insurance, universal life insurance (UL), indexed universal life insurance, variable universal life insurance (VUL), linked-benefit UL and VUL products, and critical illness and long-term care riders.